Hyfe

by Hyfe  · Based in United States → — Making Cough Count: Establishing cough as a routinely measured biomarker and endpoint to advance clinical research and transform respiratory care.
Allergy & Immunology Pulmonology Sleep Medicine

Documentation ProvidedRegulatory Status Disclosed

Overview

Hyfe is an AI-powered acoustic monitoring system designed to detect and analyze coughs. It aims to establish cough as a measurable biomarker for respiratory health.

  • What it does: Hyfe’s technology uses artificial intelligence to continuously detect and timestamp cough events in real-world settings. The AI models run on-device, processing audio locally and transmitting only metadata (timestamps), ensuring privacy by not recording or storing conversations or audio.
  • Who it is for: Hyfe is utilized by researchers, pharmaceutical companies, and healthcare providers. It is relevant for specialties involved in respiratory conditions such as chronic cough, COPD, asthma, and other ailments where cough is a significant symptom. Care settings include clinical trials, remote patient monitoring programs, and telehealth platforms.
  • How it fits a clinical or practice workflow: For clinical trials, Hyfe’s CoughMonitor Suite provides continuous, objective cough frequency data as an endpoint or for screening and adherence monitoring. In practice, it can integrate with remote patient monitoring and hospital-at-home systems to offer physicians a more informed picture of patients’ cough patterns, potentially aiding in earlier exacerbation identification and informing treatment plans.
  • Notable capabilities: Key features include continuous, long-term cough monitoring (days, weeks, or months), on-device AI processing for privacy, and a validated accuracy in detecting coughs. The system can run on various microphone-enabled devices, including wearables and smartphones.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Acoustic AI cough detection
  • Continuous cough monitoring
  • Clinically validated platform
  • Privacy-first (on-device processing)
  • Scalable for research and healthcare
  • Ultra-lightweight footprint
  • Cross-platform architecture
  • Generalizable acoustic model
  • Validated accuracy
  • APIs and SDKs for integration

Use Cases

  • Clinical trials and drug development
  • Digital therapeutics for cough hypersensitivity
  • Individual cough tracking and management
  • Respiratory health research
  • Cough insights for healthcare organizations
  • Objective measurement of cough as a biomarker

What Physicians Need to Know

Clinical Trial Matching
Hyfe's AI-powered cough monitoring is extensively used in drug development and clinical trials. It aids in patient recruitment by identifying individuals who cough via global consumer apps and in patient selection by screening for high and stable baseline cough rates to reduce the placebo effect.
Real-World Evidence Analysis
Hyfe provides objective, continuous cough monitoring in real-world settings, transforming cough from a subjective symptom into a quantifiable digital biomarker. This allows for continuous tracking over extended periods (days, weeks, or months), revealing valuable insights into longitudinal cough patterns. The system quantifies cough frequency and patterns in real-world conditions with high participant adherence, producing clinically interpretable and operationally practical data at scale.
Safety Signal Detection
While Hyfe's primary focus is cough detection, the continuous, objective monitoring of cough frequency can serve as an important efficacy endpoint in FDA-reviewed chronic cough programs. This type of objective data can contribute to a broader understanding of a drug's impact on respiratory symptoms, which could indirectly support safety signal detection by providing clearer data on symptom changes. AI-powered pharmacovigilance, in general, utilizes AI to automate data extraction and enhance signal detection from diverse real-world data sources.
Collaboration Features
Hyfe's technology powers clinical trial endpoints for pharmaceutical companies and medical device manufacturers, and supports innovative research at academic institutions and healthcare organizations worldwide. They offer various models for engagement, including monitoring as a service, licensed deployment within sponsor-led clinical trials, strategic partnerships for integration into broader therapeutic or device strategies, and embedding within third-party digital health or wearable platforms. Hyfe has partnered with ActiGraph to integrate its AI-powered cough detection into ActiGraph's wearable sensor devices for clinical trial data collection.
Publication Support
Hyfe's R&D team actively publishes peer-reviewed studies, white papers, and scientific conference abstracts related to cough monitoring, cough as a biomarker, acoustic epidemiology, and healthcare innovation. Their studies have been published in journals like BMJ Open Respiratory Research and F1000Research, and data is often made publicly available on platforms like GitHub.
Physician Tip

Hyfe's continuous, objective cough monitoring offers a significant advancement over traditional subjective or episodic assessments. Physicians can leverage this technology in clinical trials to gain a more accurate and comprehensive understanding of cough patterns and treatment efficacy in respiratory conditions. The privacy-preserving, on-device AI ensures patient data security, making it a reliable tool for long-term monitoring. Consider integrating Hyfe's data into patient management for conditions where cough is a key indicator, such as chronic cough, asthma, COPD, and heart failure, to inform personalized treatment strategies and objectively track disease progression.

Hyfe's AI cough detection models are designed with a cross-platform architecture, running seamlessly from on-device (edge) to cloud, enabling continuous monitoring on various hardware, including smartphones and wearables. The system provides structured, time-stamped outputs that can be transferred into Electronic Data Capture (EDC) systems, aligned with eCOA timestamps, or integrated into centralized data repositories. Hyfe offers APIs and SDKs for flexible integration into digital health ecosystems. Notably, Hyfe's Acoustic AI technology is integrated into the FDA-cleared ActiGraph LEAPu2122 wearable for comprehensive data collection in clinical trials.

Details

Category Drug Discovery & Research, Lab & Diagnostics, Telehealth & Virtual Care
Pricing Unknown
DeploymentOn-device (edge) to cloud, cross-platform (smartphones, wearables, clinical devices)
Mobile AppYes (CoughPro, ResolveDTx)
API Available Yes
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Pending AI-estimated
Integrations
EHR Not specified
Specialties Allergy & Immunology, Pulmonology, Sleep Medicine

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Hyfe

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Hyfe.

View all on YouTube

Frequently Asked Questions

Hyfe utilizes AI-powered cough detection and analysis to provide objective, real-world data on cough frequency and characteristics. This data can be used to assess the efficacy of new antitussive drugs, monitor disease progression in respiratory conditions, and identify potential biomarkers for drug response.
Patient compliance with Hyfe largely revolves around consistent use of the recording device (e.g., smartphone, wearable) and ensuring the device is positioned to accurately capture coughs. Clear instructions, user-friendly interfaces, and regular check-ins can help maximize adherence.
While other methods exist, such as manual cough counting by clinicians or sound-activated recorders, Hyfe offers a more automated, continuous, and less intrusive approach. Its AI algorithms are designed to differentiate coughs from other sounds, providing a higher level of accuracy and reducing observer bias.
Pricing for Hyfe's technology in drug discovery research is typically tailored to the scope and duration of the study. It often involves licensing fees for the software, per-patient data analysis costs, and potentially hardware costs if dedicated recording devices are required. Specifics would be discussed with Hyfe directly.
Limitations can include potential for background noise interference, the need for patient cooperation in device usage, and the current focus on cough frequency rather than detailed cough characteristics in some applications. While highly accurate, no system is 100% perfect, and proper study design is crucial to mitigate these.
Hyfe's AI can be trained to identify and categorize different cough characteristics, such as wet vs. dry or productive vs. non-productive, although the primary focus is often on frequency. This differentiation can be highly relevant in drug discovery to assess the specific impact of a therapeutic on different cough phenotypes.
Hyfe adheres to strict data security and privacy protocols, including HIPAA and GDPR compliance, to protect patient data. Data is typically anonymized and encrypted, and access is restricted to authorized personnel, ensuring the confidentiality and integrity of research participants' information.

Related Tools

AIRA
AIRA Healthcare
Drug Discovery & Research
AIRA is an AI platform for study design and protocol development, providing expert-level clinical, regulatory, and medical writing AI thought partners to accelerate clinical development workflows.
Biomiv
Cymetica Biosciences
Clinical Decision Support & Reference
Biomiv is an AI health research assistant that provides physicians with insights into health conditions, engineered diets, and live scientific papers and clinical trials.
TrialGPT
National Institutes of Health (NIH)
Drug Discovery & Research
An AI algorithm developed by NIH researchers to speed up the process of matching potential volunteers to relevant clinical research trials listed on ClinicalTrials.gov.
InsightRX
InsightRX
Drug Discovery & Research
InsightRX offers AI-powered precision medicine software for clinical development and point-of-care, combining agentic AI, pharmacometrics, and real-world data to enable smarter, more precise decisions for health systems and life sciences teams.
Indica Labs HALO AI
Indica Labs
Drug Discovery & Research
HALO AI is a deep-learning add-on for the HALO image analysis platform, helping users solve image analysis challenges in segmentation, classification, and phenotyping for research.
Triomics
Triomics
Clinical Decision Support & Reference
Triomics is an AI-powered platform that streamlines clinical trial matching and oncology research by integrating with EHRs to identify eligible cancer patients.

See all Drug Discovery & Research tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-08-03 | First Added: 2026-08-02

Investors who backed Hyfe

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.